Urinary Incontinence: Clinical Overview
Urinary incontinence is defined as the involuntary loss of urine. It is a common condition
that significantly impacts quality of life, physical health, and social well-being.
1. Classification and Pathophysiology
Incontinence is generally categorized based on the underlying mechanism of dysfunction:
• Stress Urinary Incontinence (SUI): Involuntary leakage on effort or exertion
(e.g., coughing, sneezing, or exercise). It is usually due to urethral hypermobility
or intrinsic sphincter deficiency.
• Urge Urinary Incontinence (UUI): Leakage accompanied by or immediately
preceded by urgency. This is often associated with detrusor overactivity.
• Mixed Urinary Incontinence (MUI): A combination of both stress and urge
symptoms.
• Overflow Incontinence: Leakage occurring when the bladder is overdistended,
often due to bladder outlet obstruction (e.g., BPH) or an acontractile detrusor
muscle.
• Functional Incontinence: Physical or cognitive impairments (e.g., severe
arthritis or dementia) that prevent the patient from reaching the toilet in time,
despite a normal urinary tract.
2. Clinical Evaluation
A thorough assessment is critical to differentiate the type of incontinence and guide
management.
• History: Focus on the onset, triggers, frequency, and volume of leakage. Assess
for "DIAPPERS" (reversible causes):
o Delirium
o Infection (UTI)
o Atrophic vaginitis
o Pharmaceuticals (diuretics, alpha-blockers)
o Psychological disorders
o Excessive urine output (diabetes)
o Restricted mobility
o Stool impaction
• Physical Examination: * Neurological exam: S2–S4 nerve roots (anal tone,
perineal sensation).
o Pelvic/Genital exam: Assess for pelvic organ prolapse or vaginal atrophy
in women; prostate exam in men.
o Stress test: Observe for leakage while the patient coughs with a full
bladder.
• Investigations:
o Urinalysis: To rule out UTI or hematuria.
o Post-Void Residual (PVR) volume: Measured via ultrasound; PVR >
200\text{ mL} suggests overflow or detrusor weakness.
o Urodynamic studies: Reserved for complex cases or before surgical
intervention.
3. Management Strategies
Conservative Management (First-line)
• Lifestyle Modifications: Fluid management, weight loss, and smoking
cessation.
• Bladder Training: Scheduled voiding to increase bladder capacity (primarily for
UUI).
• Pelvic Floor Muscle Training (PFMT): Kegel exercises to strengthen the levator
ani (primarily for SUI).
Pharmacotherapy
• For UUI: Antimuscarinics (e.g., Oxybutynin, Solifenacin) or \beta_3-
adrenoceptor agonists (e.g., Mirabegron).
• For SUI: Pharmacotherapy is limited, though topical estrogens may help
postmenopausal women with associated atrophy.
Surgical and Interventional
• SUI: Mid-urethral slings (TVT/TOT), colposuspension, or urethral bulking agents.
• UUI: Botox injections into the detrusor, or sacral neuromodulation for refractory
cases.
• Overflow: Relieving the obstruction (e.g., TURP for BPH) or clean intermittent
catheterization (CIC).
4. Summary Table
Feature Stress (SUI) Urge (UUI) Overflow
Primary Increased intra- Sudden urge/Strong
Full bladder/Obstruction
Trigger abdominal pressure desire
Leaked
Small drops/spurts Large volumes Constant dribbling
Volume
Key Bladder outlet
Sphincter weakness Detrusor overactivity
Mechanism obstruction
Initial Bladder
Pelvic floor exercises Catheterization/Surgery
Treatment training/Meds